Status:
COMPLETED
Evaluation of the Effect of Novel Recruitment Maneuver Therapy for Postoperative Pulmonary Atelectasis
Lead Sponsor:
Jilai Xiao
Conditions:
Postoperative Pulmonary Atelectasis
Negative Pressure Therapy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
1. Oxygenation index and bedside ultrasound would be used to evaluate the therapeutic effect of novel recruitment maneuver therapy in the patients with pulmonary atelectasis after cardiac surgery. 2. ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Underwent cardiac surgery with CPB
- Patients with lung ultrasound evidence of atelectasis after surgery
- Agree to participate in this study by themselves or their family member.
Exclusion
- Vasoactive-inotropic score (VIS)\>20
- Patients who were not suitable for using abdominal CPR compression-decompression instrument: bleeding from abdominal organs, abdominal aortic aneurysm, large abdominal tumor, intra-abdominal hypertension, etc
- Hemothorax or large pleural effusion confirmed by ultrasonography/X-ray
- Pneumothorax or air leak confirmed by ultrasonography/X-ray
- Considered by other researchers to be unsuitable for participation in this study
Key Trial Info
Start Date :
September 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 20 2024
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT06049173
Start Date
September 10 2023
End Date
April 20 2024
Last Update
December 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing First Hospital
Nanjing, Nanjing, China, 210000